IRIS
PASTA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.160
AS - Asia 1.012
NA - Nord America 920
SA - Sud America 90
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.205
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.955
US - Stati Uniti d'America 858
SG - Singapore 356
CN - Cina 296
VN - Vietnam 174
BD - Bangladesh 93
FR - Francia 60
BR - Brasile 56
CA - Canada 41
FI - Finlandia 39
HK - Hong Kong 34
DE - Germania 27
AR - Argentina 22
GB - Regno Unito 20
MX - Messico 12
JP - Giappone 9
NL - Olanda 9
ID - Indonesia 8
IE - Irlanda 7
IN - India 7
UA - Ucraina 6
AT - Austria 5
PH - Filippine 5
PL - Polonia 5
EG - Egitto 4
ES - Italia 4
IQ - Iraq 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AU - Australia 3
CH - Svizzera 3
EC - Ecuador 3
MY - Malesia 3
RU - Federazione Russa 3
SE - Svezia 3
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.205
Salva come PNG Salva come JPEG
Città #
Genoa 1.996
Vado Ligure 412
Genova 224
San Jose 187
Singapore 153
Ashburn 134
Rapallo 114
New York 69
Council Bluffs 66
Beijing 59
Lauterbourg 54
Hanoi 48
Ho Chi Minh City 44
Boardman 34
Hong Kong 32
Los Angeles 27
Santa Clara 25
Rome 23
Milan 22
Chicago 21
Frankfurt am Main 21
Helsinki 21
Lappeenranta 18
Orem 14
Turin 13
Dallas 11
Mexico City 10
Montreal 10
St Louis 10
Tianjin 10
Toronto 10
Buffalo 9
Haiphong 9
Tokyo 9
Atlanta 8
Camaiore 8
Da Nang 8
Naples 8
Dublin 7
Bordighera 6
Bologna 5
Charlotte 5
Memphis 5
Salt Lake City 5
Tampa 5
Warsaw 5
Brescia 4
Can Tho 4
Guangzhou 4
Kyiv 4
Manchester 4
Phoenix 4
São Paulo 4
Tashkent 4
Vienna 4
Biên Hòa 3
Brooklyn 3
Buenos Aires 3
Cairo 3
Cardiff 3
Catania 3
Hải Dương 3
London 3
Marseille 3
Miano 3
Piscataway 3
Poplar 3
Stockholm 3
Addis Ababa 2
Albuquerque 2
Amsterdam 2
Baghdad 2
Bari 2
Belleville 2
Brugherio 2
Cagliari 2
Charleston 2
Chennai 2
Cinisello Balsamo 2
City of London 2
Colton 2
Des Moines 2
Duque de Caxias 2
Elk Grove Village 2
Gresham 2
Johannesburg 2
Kingston 2
Kuala Lumpur 2
Longview 2
Louisville 2
Lấp Vò 2
Madrid 2
Messina 2
Miami 2
Milwaukee 2
Miramar 2
Monza 2
Nairobi 2
Ninh Bình 2
Padua 2
Totale 4.133
Salva come PNG Salva come JPEG
Nome #
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 162
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 143
PCSK9 inhibitors for treating hypercholesterolemia 134
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 133
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 130
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 122
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 113
Esophageal motor disorders across ages: A retrospective multicentric analysis 106
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 105
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 101
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 99
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 97
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 88
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 86
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 85
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 85
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 84
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 83
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study 83
Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria 82
Clopidogrel-Induced Eosinophilic Colitis 82
Food Intolerances, Food Allergies and IBS: Lights and Shadows 80
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection 79
The crohn's disease exclusion diet in adults with mild-to-moderate crohn’s disease activity: A real-world open-label randomized controlled trial 79
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 79
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 79
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis 75
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 74
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 74
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 74
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 73
Diagnostic delay in achalasia 73
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 72
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 71
Assessing the short-term prognosis of patients with cirrhosis using the DIC scores 71
Role of dietary intervention in patients with metabolic syndrome and {NAFLD}-{NASH} 69
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 69
Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease 69
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 68
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome 66
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance? 63
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission 61
Hepatocellular carcinoma in patients with Autoimmune Hepatitis 61
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 60
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis 59
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 59
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 58
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 56
Exploring new noninvasive parameters to predict oesophageal varices in patients with NAFLD-associated compensated liver cirrhosis 56
Decline in LDL-C control in patients with dyslipidemia treated with PCSK9-inhibitors: The role of obesity in LDL-C target achievement 55
Surveillance for hepatocellular carcinoma in patients with Primary Biliary Cholangitis: for all or just for some? 54
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis 54
Evaluation of adherence to Mediterranean diet, assessed by a food frequency questionnaire, in dyslipidemic patients and evaluation of dietary intervention efficacy 54
Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management 53
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NON-CARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 51
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration 51
The levels of lipoprotein (a) in the modulation of carotid atherosclerosis risk in a group of patients with metabolic syndrome in primary prevention 50
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 47
Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations 47
Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply 45
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 45
Is global score better than a single histological parameter for assessing microscopic esophagitis? 43
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting 41
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 38
Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis 37
Prevalence of Dysphagia and Its Health Implications Among Elderly Residents in Long-Term Care Facilities in the Liguria Region (Italy): An Observational Cohort Study 36
Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinician 36
Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis 33
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 30
null 30
Resolution of Hepatitis Delta Virus-related Cryoglobulinemic Vasculitis with the Use of Bulevirtide: a Case Report 28
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 28
Assessment of Esophagogastric Junction Barrier Function With the Supine‐Upright Transition of the Chicago Classification Protocol 26
Dietary and Nutraceutical Interventions for Functional Dyspepsia: A Narrative Review 25
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 24
Health inequalities in patients with cirrhosis: investigating the impact of material deprivation on patients’ outcomes. 23
The promise and pitfalls of Emerging Potassium-Competitive Acid Blockers for the treatment of Gastroesophageal reflux disease 22
The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions 22
Optimizing bracnh-duct intraductal papillary mucinous neoplasms surveillance: data-driven dimensional grouping for risk stratification and cost-effectiveness. The PACMANS Study 21
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 20
Sustained Virologic Response and Prognosis in HCV-related Hepatocellular Carcinoma: Lessons from Complementary Cohorts 19
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes 18
Evaluation of the diagnostic accuracy of two esophageal biopsy sites compared to three in histological follow-up of eosinophilic esophagitis – A multicentric study 17
Comparative efficacy of initial treatment strategies in patients with TACE-unsuitable hepatocellular carcinoma 17
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components 17
Corrigendum to “Esophageal motility disorders among elderly patients: An international multicenter study” [Digestive and Liver Disease 57 (2025) 1615-1621] 14
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 14
Recurrent hepatic encephalopathy after abdominal surgery in a non-cirrhotic patient: a case report. 13
Chronic Liver Disease, Liver Damage, and Liver Failure after Hypoabsorptive Bariatric Surgery: A Dose-Dependent Relationship and Multisystemic Consequences 13
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study 11
Esophageal motility disorders among elderly patients: An international multicenter study 11
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 10
It takes two to tango: Preserving liver function competes with response to systemic therapy in patients with HCC and decompensated cirrhosis 9
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction 8
Mean Nocturnal Baseline Impedance in Gastroesophageal Reflux Disease: Considerations on the Study by Lee et al 6
Esophageal Function Testing Identifies Barrett’s Esophagus Patients With Pathological Acid Exposure at Risk for Neoplasia 2
Research gaps in eosinophilic esophagitis: unanswered questions and future directions 1
Totale 5.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.731
article - articoli 18.731
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022125 7 0 0 4 15 12 0 29 21 13 5 19
2022/2023150 17 19 3 5 22 19 13 11 19 1 17 4
2023/2024275 9 21 2 32 15 31 23 14 22 21 28 57
2024/20251.253 59 53 50 91 136 111 111 231 52 41 170 148
2025/20263.580 296 98 349 336 405 211 390 194 336 497 350 118
Totale 5.499